VolitionRX Insider Files: 9,727 RSUs Granted to Chief Commercial Officer
Rhea-AI Filing Summary
Gael Forterre, Chief Commercial Officer of VolitionRx Limited (VNRX), was awarded 9,727 restricted stock units (RSUs) on August 15, 2025 in lieu of cash compensation. The RSUs are payable in shares upon settlement and will be earned in six approximately equal monthly installments beginning September 1, 2025. Once earned, the RSUs remain subject to additional time-based vesting in two installments of 4,864 units on November 1, 2025 and 4,863 units on February 1, 2026, and require continued service for each applicable earning and vesting date.
Following the award, Mr. Forterre directly beneficially owns 166,427 shares and indirectly holds 5,000 shares through his spouse and 32,500 shares managed by Armorica Partners, LLC, of which he is the managing director and sole shareholder; he disclaims beneficial ownership except for pecuniary interest.
Positive
- RSU grant of 9,727 units awarded in lieu of cash, aligning executive compensation with shareholder interests
- Clear vesting schedule: six monthly earning installments starting 09/01/2025 and two time-based vesting installments on 11/01/2025 and 02/01/2026
- Transparent disclosure of indirect holdings managed by Armorica Partners, LLC and relationship of reporting person to that entity
Negative
- None.
Insights
TL;DR: Insider compensation granted as RSUs replaces cash pay and modestly increases potential share-based holdings, appearing routine.
The August 15, 2025 award of 9,727 RSUs to the Chief Commercial Officer in lieu of cash compensation converts cash obligations into equity-based compensation that vests over defined service periods. The award schedule—six monthly earning installments followed by two time-based vesting installments—spreads recognition and aligns retention incentives. Reported direct beneficial ownership of 166,427 shares provides context for the executive's stake but does not in itself indicate a controlling position. This filing is a standard Section 16 disclosure of insider compensation and holdings and is not, on its face, an unusual or immediately material corporate event.
TL;DR: The filing documents routine equity compensation and clarifies indirect holdings through a management vehicle and spouse.
The Form 4 details compensation governance: RSUs awarded under the 2015 Stock Incentive Plan with explicit earning and vesting milestones, tying settlement to continued service. The disclosure that Armorica Partners, LLC manages 32,500 shares and that Mr. Forterre is its managing director and sole shareholder provides required transparency about indirect holdings and voting/dispositive control, while the disclamation of beneficial ownership except for pecuniary interest follows standard practice. Timely filing and signature complete the regulatory obligations.